procainamide has been researched along with Muscular Atrophy in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, ED | 1 |
| Krasilnikoff, PA | 1 |
| Overvad, H | 1 |
1 other study available for procainamide and Muscular Atrophy
| Article | Year |
|---|---|
Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?
Topics: Abnormalities, Multiple; Anodontia; Blepharoptosis; Cardiac Complexes, Premature; Child; Cleft Palat | 1971 |